John P. Schmid, CFO and Secretary at Trius Therapeutics Inc (TSRX), sold 700 shares at $7.50 ($5K) on 2011-12-01, disclosed to the SEC on 2011-12-02.
Scheduled sale ($5k) by CFO and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| XERS | BUY | 2024-08-13 | $10K | — | Filing → |
| XERS | BUY | 2024-08-12 | $10K | — | Filing → |
| XERS | BUY | 2024-05-10 | $10K | — | Filing → |